COVID-19/tuberculosis interaction: how the persistence of a millennial disease impacts the severity of an emerging pandemic
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/19754 |
Resumo: | COVID-19 is a communicable disease caused by the SARS-CoV-2 virus, which emerged in December 2019, in China. Such a pathogen has spread across the globe in an uncontrolled manner, culminating in a pandemic that has been causing disastrous impacts. In most deaths from COVID-19, hypertension, obesity, diabetes mellitus, heart disease, and respiratory conditions, such as tuberculosis, were present. Tuberculosis is a disease caused by the bacteria Mycobacterium tuberculosis, and is a major public health problem worldwide due to its wide geographic dispersion, cases of multidrug resistance, and because it is a relevant factor for morbidity and mortality. In addition, its main characteristic is pulmonary involvement, which is of great concern when associated with cases of COVID-19. The objective of this work is to systematize information, critically contextualizing the central issue about the COVID-19/tuberculosis interaction, seeking to analyze evidence described on the subject with emphasis on its direct and indirect impacts. To this end, an integrative literature review was conducted, outlined by searching for bibliographies and scientific articles in the main electronic repositories. The descriptors used were: tuberculosis, COVID-19, impact, coinfection, history, epidemiology, risk factors, diagnosis, vaccine, and clinical/laboratory changes. Finally, we note that the COVID-19/tuberculosis interaction is associated with unfavorable and lethal outcomes for patients, as well as indirect impacts. Therefore, new strategies for the control/management of both diseases are of great urgency. However, knowledge on the subject is still limited, with the need for further studies on the possible variables and effects still unknown. |
id |
UNIFEI_eae146843315ae9c324e3ae152cda66e |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/19754 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
COVID-19/tuberculosis interaction: how the persistence of a millennial disease impacts the severity of an emerging pandemicInteracción COVID-19/tuberculosis: cómo la persistencia de uma enfermedad milenaria influye en la gravedad de una pandemia emergenteInteração COVID-19/tuberculose: como a persistência de uma doença milenar impacta na gravidade de uma pandemia emergenteTuberculosisCOVID-19ImpactoCoinfecciónHistoriaEpidemiologíaFactores de riesgoDiagnósticoVacunaCambios clínicos/laborales.TuberculosisCOVID-19ImpactCoinfectionHistoryEpidemiologyRisk factorsDiagnosisVaccineClinical/laboratory changes.TuberculoseCOVID-19ImpactoCoinfecçãoHistóricoEpidemiologiaFatores de riscoDiagnósticoVacinaAlterações clínico/laboratoriais.COVID-19 is a communicable disease caused by the SARS-CoV-2 virus, which emerged in December 2019, in China. Such a pathogen has spread across the globe in an uncontrolled manner, culminating in a pandemic that has been causing disastrous impacts. In most deaths from COVID-19, hypertension, obesity, diabetes mellitus, heart disease, and respiratory conditions, such as tuberculosis, were present. Tuberculosis is a disease caused by the bacteria Mycobacterium tuberculosis, and is a major public health problem worldwide due to its wide geographic dispersion, cases of multidrug resistance, and because it is a relevant factor for morbidity and mortality. In addition, its main characteristic is pulmonary involvement, which is of great concern when associated with cases of COVID-19. The objective of this work is to systematize information, critically contextualizing the central issue about the COVID-19/tuberculosis interaction, seeking to analyze evidence described on the subject with emphasis on its direct and indirect impacts. To this end, an integrative literature review was conducted, outlined by searching for bibliographies and scientific articles in the main electronic repositories. The descriptors used were: tuberculosis, COVID-19, impact, coinfection, history, epidemiology, risk factors, diagnosis, vaccine, and clinical/laboratory changes. Finally, we note that the COVID-19/tuberculosis interaction is associated with unfavorable and lethal outcomes for patients, as well as indirect impacts. Therefore, new strategies for the control/management of both diseases are of great urgency. However, knowledge on the subject is still limited, with the need for further studies on the possible variables and effects still unknown.COVID-19 es una enfermedad transmisible causada por el virus SARS-CoV-2, que surgió en diciembre de 2019, en China. Dicho patógeno se ha extendido por todo el mundo de forma incontrolada, culminando en una pandemia que ha causado impactos desastrosos. En la mayoría de las muertes por COVID-19, estaban presentes la hipertensión, obesidad, diabetes mellitus, enfermedades cardíacas y afecciones respiratórias, como la tuberculosis. La tuberculosis es una enfermedad causada por la bacteria Mycobacterium tuberculosis, y constituye un importante problema de salud pública en todo el mundo debido a su amplia dispersión geográfica, a los casos de multirresistencia y a que es un factor relevante de morbilidad y mortalidad. Además, su principal característica es la afectación pulmonar, que es muy preocupante cuando se asocia a casos de COVID-19. El objetivo de este trabajo es realizar una sistematización de la información, contextualizando de forma crítica el tema central sobre la interacción COVID-19/tuberculosis, buscando analizar las evidencias descritas sobre el tema con énfasis en sus impactos directos e indirectos. Para ello, se realizó una revisión bibliográfica integradora, perfilada por la búsqueda de bibliografías y artículos científicos en los principales repositorios electrónicos. Los descriptores utilizados fueron: tuberculosis, COVID-19, impacto, coinfección, historia, epidemiología, factores de riesgo, diagnóstico, vacuna y cambios clínicos/laborales. Por último, se observa que la interacción COVID-19/tuberculosis está asociada a situaciones desfavorables y letales para los pacientes, así como a impactos indirectos. Por lo tanto, urgen nuevas estrategias para el control/manejo de ambas enfermedades. Sin embargo, los conocimientos sobre el tema son todavía limitados, donde hay necesidad de realizar más estudios sobre las posibles variables y efectos desconocidos.A COVID-19 é uma doença transmissível causada pelo vírus SARS-CoV-2, que emergiu em dezembro de 2019, na China. Tal patógeno se disseminou por todo o globo terrestre de maneira descontrolada, culminando em uma pandemia que vem causando impactos desastrosos. Na maioria dos óbitos por COVID-19, a hipertensão arterial, obesidade, diabetes mellitus, doença cardíaca e quadros respiratórios, como a tuberculose, estavam presentes. A tuberculose é uma doença causada pela bactéria Mycobacterium tuberculosis, sendo um grande problema de saúde pública mundial devido a sua ampla dispersão geográfica, casos de multirresistência, e por ser um fator relevante de morbimortalidade. Além disso, possui como característica principal o comprometimento pulmonar, o que é de grande preocupação quando associado aos casos de COVID-19. O objetivo deste trabalho é realizar uma sistematização de informações, contextualizando de forma crítica a problemática central sobre a interação COVID-19/tuberculose, buscando analisar evidências descritas sobre o tema com ênfase em seus impactos diretos e indiretos. Para tanto, realizou-se uma revisão bibliográfica integrativa, delineada pela busca de bibliografias e artigos científicos nos principais repositórios eletrônicos. Os descritores utilizados foram: tuberculose, COVID-19, impacto, coinfecção, histórico, epidemiologia, fatores de risco, diagnóstico, vacina e alterações clínico/laboratoriais. Por fim, nota-se que a interação COVID-19/tuberculose está associada a quadros desfavoráveis e letais aos pacientes, assim como a impactos indiretos. Logo, novas estratégias para o controle/manejo de ambas as doenças são de grande urgência. Todavia, o conhecimento sobre a temática ainda é limitado, havendo a necessidade de estudos mais aprofundados acerca das possíveis variáveis e efeitos ainda desconhecidos.Research, Society and Development2021-09-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1975410.33448/rsd-v10i11.19754Research, Society and Development; Vol. 10 No. 11; e305101119754Research, Society and Development; Vol. 10 Núm. 11; e305101119754Research, Society and Development; v. 10 n. 11; e3051011197542525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/19754/17552Copyright (c) 2021 Leonardo Linhares Miler da Silva; Rodrigo Grazinoli Garridohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Leonardo Linhares Miler daGarrido, Rodrigo Grazinoli2021-10-23T19:01:11Zoai:ojs.pkp.sfu.ca:article/19754Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:39:35.633708Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
COVID-19/tuberculosis interaction: how the persistence of a millennial disease impacts the severity of an emerging pandemic Interacción COVID-19/tuberculosis: cómo la persistencia de uma enfermedad milenaria influye en la gravedad de una pandemia emergente Interação COVID-19/tuberculose: como a persistência de uma doença milenar impacta na gravidade de uma pandemia emergente |
title |
COVID-19/tuberculosis interaction: how the persistence of a millennial disease impacts the severity of an emerging pandemic |
spellingShingle |
COVID-19/tuberculosis interaction: how the persistence of a millennial disease impacts the severity of an emerging pandemic Silva, Leonardo Linhares Miler da Tuberculosis COVID-19 Impacto Coinfección Historia Epidemiología Factores de riesgo Diagnóstico Vacuna Cambios clínicos/laborales. Tuberculosis COVID-19 Impact Coinfection History Epidemiology Risk factors Diagnosis Vaccine Clinical/laboratory changes. Tuberculose COVID-19 Impacto Coinfecção Histórico Epidemiologia Fatores de risco Diagnóstico Vacina Alterações clínico/laboratoriais. |
title_short |
COVID-19/tuberculosis interaction: how the persistence of a millennial disease impacts the severity of an emerging pandemic |
title_full |
COVID-19/tuberculosis interaction: how the persistence of a millennial disease impacts the severity of an emerging pandemic |
title_fullStr |
COVID-19/tuberculosis interaction: how the persistence of a millennial disease impacts the severity of an emerging pandemic |
title_full_unstemmed |
COVID-19/tuberculosis interaction: how the persistence of a millennial disease impacts the severity of an emerging pandemic |
title_sort |
COVID-19/tuberculosis interaction: how the persistence of a millennial disease impacts the severity of an emerging pandemic |
author |
Silva, Leonardo Linhares Miler da |
author_facet |
Silva, Leonardo Linhares Miler da Garrido, Rodrigo Grazinoli |
author_role |
author |
author2 |
Garrido, Rodrigo Grazinoli |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Silva, Leonardo Linhares Miler da Garrido, Rodrigo Grazinoli |
dc.subject.por.fl_str_mv |
Tuberculosis COVID-19 Impacto Coinfección Historia Epidemiología Factores de riesgo Diagnóstico Vacuna Cambios clínicos/laborales. Tuberculosis COVID-19 Impact Coinfection History Epidemiology Risk factors Diagnosis Vaccine Clinical/laboratory changes. Tuberculose COVID-19 Impacto Coinfecção Histórico Epidemiologia Fatores de risco Diagnóstico Vacina Alterações clínico/laboratoriais. |
topic |
Tuberculosis COVID-19 Impacto Coinfección Historia Epidemiología Factores de riesgo Diagnóstico Vacuna Cambios clínicos/laborales. Tuberculosis COVID-19 Impact Coinfection History Epidemiology Risk factors Diagnosis Vaccine Clinical/laboratory changes. Tuberculose COVID-19 Impacto Coinfecção Histórico Epidemiologia Fatores de risco Diagnóstico Vacina Alterações clínico/laboratoriais. |
description |
COVID-19 is a communicable disease caused by the SARS-CoV-2 virus, which emerged in December 2019, in China. Such a pathogen has spread across the globe in an uncontrolled manner, culminating in a pandemic that has been causing disastrous impacts. In most deaths from COVID-19, hypertension, obesity, diabetes mellitus, heart disease, and respiratory conditions, such as tuberculosis, were present. Tuberculosis is a disease caused by the bacteria Mycobacterium tuberculosis, and is a major public health problem worldwide due to its wide geographic dispersion, cases of multidrug resistance, and because it is a relevant factor for morbidity and mortality. In addition, its main characteristic is pulmonary involvement, which is of great concern when associated with cases of COVID-19. The objective of this work is to systematize information, critically contextualizing the central issue about the COVID-19/tuberculosis interaction, seeking to analyze evidence described on the subject with emphasis on its direct and indirect impacts. To this end, an integrative literature review was conducted, outlined by searching for bibliographies and scientific articles in the main electronic repositories. The descriptors used were: tuberculosis, COVID-19, impact, coinfection, history, epidemiology, risk factors, diagnosis, vaccine, and clinical/laboratory changes. Finally, we note that the COVID-19/tuberculosis interaction is associated with unfavorable and lethal outcomes for patients, as well as indirect impacts. Therefore, new strategies for the control/management of both diseases are of great urgency. However, knowledge on the subject is still limited, with the need for further studies on the possible variables and effects still unknown. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-09-02 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/19754 10.33448/rsd-v10i11.19754 |
url |
https://rsdjournal.org/index.php/rsd/article/view/19754 |
identifier_str_mv |
10.33448/rsd-v10i11.19754 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/19754/17552 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Leonardo Linhares Miler da Silva; Rodrigo Grazinoli Garrido https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Leonardo Linhares Miler da Silva; Rodrigo Grazinoli Garrido https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 11; e305101119754 Research, Society and Development; Vol. 10 Núm. 11; e305101119754 Research, Society and Development; v. 10 n. 11; e305101119754 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052688315187200 |